Basaglar (insulin glargine)

pCPA File Number: 20930

Negotiation Status:

Concluded with an LOI

Indication(s):

Diabetes Mellitus, Type 1 & 2

Sponsor/Manufacturer:

Eli Lilly Canada Inc.

CADTH Project Number:

SE0451-000

pCPA Engagement Letter Issued:

2016-06-15

Negotiation Process Concluded:

2017-07-07